Smooth Muscle Cells in Vascular Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 291
Special Issue Editor
Interests: atherosclerosis; vascular smooth muscle cell; inflammation; endothelium; cell senescence; apoptosis; lipid metabolism; oxidative stress; nitric oxide; exosomes; vascular calcification; cytokines; growth factors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vascular smooth muscle cells (SMCs) are the major constituents of medium- and large-sized arteries. They are arranged in a helical pattern around the vessel lumen and play a key role in controlling blood pressure and blood distribution, as well as maintaining vascular structural integrity. In addition to their physiological properties, SMCs have also been strongly implicated in the pathogenesis of vascular diseases, particularly atherosclerosis, aortic aneurysm and pulmonary hypertension. Unlike adult skeletal or cardiac muscle, which are terminally differentiated, adult SMCs retain remarkable plasticity and can undergo profound and reversible changes in phenotype in response to stimuli or inputs from the environment. In normal healthy arteries, SMCs adopt a quiescent, contractile phenotype characterized by an elongated spindle-shaped morphology and express a unique repertoire of proteins and signaling molecules required for their contractile function. Upon vascular injury, aging or disease states, contractile SMCs can switch to a less differentiated state, characterized by a reduced expression of contractile proteins, and can acquire alternative phenotypes, transforming into foam cells, inflammatory-like cells, mesenchymal stem cells and osteochondrogenic cells, which can contribute both positively and negatively to disease progression. The molecular regulation of SMC behavior involves transcriptional factors, microRNAs and their target genes, epigenetic modifications and numerous environmental cues including growth factor/cytokines, cell–cell contact, extracellular matrix interactions, mechanical force and noxious stimuli. SMC senescence has been also associated with atherosclerosis development. Similar to other cell types, senescent SMCs display defective proliferative potential, increased levels of senescence markers and enhanced cell death. Moreover, senescent SMCs exhibit a more synthetic phenotype and an abnormal response to the vasoactive and regulating peptides produced in the vascular endothelium.
This Special Issue on “Smooth Muscle Cells in Vascular Disease” welcomes original research articles and reviews in the field, with a focus on (but not limited to) the molecular mechanisms that regulate the phenotypic plasticity of SMCs, their potential for monoclonal or oligoclonal expansion, the aberrant interplay between endothelial cells (ECs) and SMCs and the dysregulated signaling pathways activated within the SMCs that contribute to the onset and progression of vascular diseases. I also encourage submissions that aim to define new perspectives and therapeutic strategies targeting SMC-related pathways to clinically treat vascular remodeling and its complications.
Dr. Ida Daniela Perrotta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- smooth muscle cells (SMCs)
- atherosclerosis
- hypertension
- aortic aneurysm
- vascular ageing
- extracellular matrix
- endothelial cells (ECs)
- SMC senescence
- interleukin
- platelet-derived growth factor
- phenotype switching
- SMC plasticity
- SMC-derived cells
- molecular subtypes
- intimal thickening
- plaque stability
- transcription factors
- microRNAs
- clonality
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
